ArticleArchives of plastic surgery2025
Galactorrhea after Breast Augmentation with Mastopexy: Case Reports and Literature Review.
Article in Archives of plastic surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Galactorrhea is a rare but well-described complication following aesthetic breast surgery. Augmentation with mastopexy is a procedure that combines breast tissue reduction with volume augmentation; however, only few cases of galactorrhea were described following this procedure. This report concerns three cases of galactorrhea after augmentation with mastopexy provided by two surgeons (J.P. and M.P.). Patients did not report any significant gynecological history, including a history of oral hormonal intake or galactorrhea in the past. All three patients underwent the dual plane breast augmentation together with the Wise-pattern breast lift. In two cases, the first symptoms occurred in the second week, and in one case in the third week after surgery, manifesting as breast pain and swelling. These clinical issues, accompanied by a small amount of white fluid secretion from the vertical scar, scar around nipple-areolar complex, and from the T-junction, were presented to the operating surgeons. Galactorrhea came to consideration after a negative microbiological examination. In two cases, galactorrhea was treated with oral dopaminergic medication cabergoline, with a good response to the therapy. All symptoms, including redness and pain, fully resolved at the 21st postoperative day without the necessity of surgical revision. One patient with bilateral secretion was treated by early operative revision. In the following days, secretion ceased, and after drain removal, further complications did not occur. Aesthetic results after 12 months were satisfactory in all patients. In conclusion, galactorrhea is a rare but significant complication of any mammaplasty surgery. Untreated secretion may lead to severe complications; however, early recognition and treatment may lead to good results and patient satisfaction.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.